Excellence Scholarships
IVID Graduate Programme
Call for applications from November 06 to January 31
We are pleased to announce the launch of the Excellence Scholarship Campaign for Masters students who wish to attend one of the masters of the IVID Graduate Programme.
About the IVID Graduate Programme
The IVID Graduate Programme aims at training students in the fields of Immunology, Vaccinology and Infectious diseases.
These scholarships are intended for foreign students wishing to enroll in the 3 BMC Master’s degree:
- M2 Infectiology
- M2 Immunology, Immunopathology, Immunotherapy (3i)
- The Erasmus Mundus Living International Vaccinology Education pathway, with a specific M1 and M2 (LIVE)
The BMC M2 Infectiology master’s degree offers students who have completed their first year of M1 or equivalent (health studies, veterinary medicine, etc.) a high-level training in Molecular and Cellular Biology, Virology, Microbiology, Host-Pathogen Relations, Immunology and Vaccinology, with a specialization in “IF” : Fundamental Infectiology, with the aim of completing an academic research project (“master thesis”) followed by a doctoral thesis, or “IA”: Applied Infectiology, with the aim of a 5-year post-graduate diploma in industry and the socio-economic world in general. The program consists of 60% UE taught in English (Scientific Communication; Scientific English; Technology Watch ; one pratical UEs to choose between Vaccinology, Virology, or Infectious Bacteriology ; Antimicrobial & Vaccine Therapeutic Innovation ; Advanced Virology (lectures); Bacteriology and Parasitology (lectures); Immunology and Cancer ; Epidemiology; MOOC Vaccinology and Infodemiology) and 40% UE taught in French (Statistical Analysis and Bioinformatics; Biosafety and Prevention of Biological Risks Legal and Regulatory Aspects in Living Systems; Business Culture ; Viral Infection Strategy; Bacterial Infection Strategy ; Infectious Disease Prevention )
The BMC “Immunology Immunopathology Immunotherapy” Master 2’s degree (M2 3i) is open to students with a Master 1 or equivalent (scientific studies, health studies, veterinary medicine, and related fields.). The M2 3i offers high-level, cutting-edge training in fundamental, translational and clinical immunology for students seeking advanced training in fundamental and applied antimicrobial / antitumoral immunology, neuro-immunology and immunopathologies (autoimmunity, inflammatory diseases). The M2 3i courses are taught in English and are open to international students. Teaching units include lectures by experts in their field, featuring introductory overviews and presentations of cutting-edge data. Pathologies involving defective immune responses are presented in relation to current and future therapies which aimed at modulating the immune response. Teaching units include ‘Advanced Fundamental Immunology’, ‘Translational Immunopathology’, ‘Clinical Immunotherapy’, ‘Immunity and Infection’, ‘Immunity and Cancer’, ‘Neuro-immunology’, as well as training in English, biostatistics and scientific communication. A 6-month research training in a French or foreign immunology laboratory completes the formation. The M2 3i offers training for students wishing to continue their training with a Ph.D. or pursue a career in industry-immunology.
The Erasmus Mundus Joint Master “Leading International Vaccinology Education – LIVE” (https://masterlive-vaccinology.eu) welcomes motivated Scientists, Bioeng, Clinicians, PharmD and Vet, with a C1 English level and a BSc level in cell/mol biol, biochem, microbio, physio and immunology. LIVE educates students into skilled vaccinologists adapted to our changing world. LIVE awards 120 ECTS in advanced immunology, infectiology, vaccine research &, innovation, preclin. and clinical dvpt to scale-up production of quality vaccine, manage regulatory affairs, communicate on vaccines in public health, foster access to existing and new safe vaccines, support health economics pillars, and fight epi/pandemics, for future vaccines to save more lives. LIVE is produced by 5 leading universities with semester 1 (S1) jointly at Universitat Autònoma de Barcelona and Universitat de Barcelona (ES), S2 at Universiteit Antwerpen (BE), S3 jointly at Université Jean Monnet Saint-Etienne and Université Claude Bernard Lyon 1 (FR), in close collaboration with 61 associated partners (AP) from 23 countries. LIVE APs cover the vaccinology labour chain to host LIVE students for their 6-mo professional S4 internship in academia or private (50/50) institutions, promoting internationality, creativity and employability. Applicants with 4-year successful higher education and passing the M1 LIVE equivalence jury, access the M2 LIVE, for training in vaccine research, industry, and communication, before their 6-mo professional internship. LIVE will educate 120+ vaccinologists of 50+ nationalities by 2030, connected to the LIVE Alumni family, to tackle challenges for developing prophylactic and therapeutic vaccines. With their “Reality projects”, students imagine a “green” future for vaccines, lowering negative impacts of Anthropocene: from vaccine production and administration to adaptive vaccinology quickly dealing with climate change-induced emerging diseases and benefiting from Artificial Intelligence for innovation. After graduation, most (65%) LIVE vaccinologists intensify their creativity in doctoral research.
IVID training programs are part of the Graduate+ project involving four French universities on the Lyon – Saint-Etienne site: Université Claude Bernard Lyon 1, Ecole Normale Supérieure de Lyon, Université Jean Moulin and Université Jean Monnet.
Graduate+ proposes 15 transdisciplinary thematic programmes of excellence from undergraduate to doctoral level, intensive immersion into the world of research, scholarships for international students as well as scholarships for international mobility.
Scholarship amount
The amount of the scholarship is €1000 per month for 10 months, totaling €10 000 € per year per recipient for 1 or 2 years (M2 or M1 access).
Eligibility criteria
To be a foreign student, newcomer to a French university and living outside of France at the time of the application (French dual citizenship allowed)
Having obtained a Bachelor degree or 1 year of Master before next July 15 (deadline) in the field of biosciences, or medical or veterinary or pharmaceutical sciences or any field related to IVID.
Award criteria
- Excellence of the academic background
- Internship experiences and technical skills in research
- Motivation and consistency of the professional project
Application Procedure
Submissions open: November 6th, 2024
Deadline for applications: January 31th, 2025
Candidates must send their application as a single file in PDF format to the following address: patricia.doublet@univ-lyon1.fr or to the MyLIVE platform for the Master LIVE applicants)
To be enclosed with the application:
- Proof of higher education diplomas: at least a Bachelor level to apply for M1 LIVE or four years or successful higher education to apply for M2 Infectiology or 3i or LIVE (180 or 240 ECTS for European students, respectively)
- Curriculum Vitae (1 page)
- Motivation letter: 1 page explaining how this Master will support the candidate’s career goals and what motivates this Master choice at Université Claude Bernard Lyon 1
- Description of studies
- Transcripts of records related to the Diploma supporting academic eligibility
- If applicable, abstracts of the candidate’s previous work (e.g. dissertation, books, internship reports, scientific articles…).
- Certificate of English level (TOEFL, IELTS, ECRL), except for English native speakers
- Certificate of French level for M2 Infectiology
- Copy of an official identity document
IMPORTANT: Separately, one or two letter(s) of recommendation must be sent to the following address: patricia.doublet@univ-lyon1.fr. This letter(s) has to be written by former or current professors, lecturers, tutors or supervisors. This/these letter(s) must be submitted by the referee(s), and not directly by the applicant.
UPDATE: The selection process for the GI IVID excellence scholarships, which depends on the admission procedure for the three programs (Infectiology, 3i, and LIVE), has been revised. As a result, the scholarship award schedule has been adjusted, and the announcement of results has been postponed to March 27, 2025.
Administrative prodecure
In parallel with the above procedure, students should act according to their situation and apply to the training programme on the dedicated national platforms.
These two procedures are independent of each other but compulsory.
Information can be found on the Graduate + website: